DexCom, Inc.
DXCM
Classement en actions
#759
DexCom, Inc. is a medical technology company primarily focused on innovating,... DexCom, Inc. is a medical technology company primarily focused on innovating, developing, and marketing continuous glucose monitoring (CGM) systems. Operating across the United States and internationally, the firm provides its solutions for individuals managing diabetes as well as for healthcare practitioners. Its product portfolio features the DexCom G6, a comprehensive CGM system for diabetes management; the Dexcom Real-Time API, enabling authorized third-party developers to integrate live CGM data into their digital health applications; the Dexcom ONE, which aims to supersede traditional finger-prick blood glucose testing for treatment decisions; and Dexcom Share, a remote monitoring platform. The company is also developing the Dexcom G7, its next-generation CGM system. Furthermore, DexCom, Inc. has a licensing and collaboration agreement with Verily Life Sciences LLC and Verily Ireland Limited to advance blood-based or interstitial glucose monitoring products. The company directly sells its offerings to specialists such as endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and maintains its headquarters in San Diego, California.
Prix de l'action
$85.72
Dernière synchronisation: 2026-10-20
Capitalisation boursière
$32.35B
Changement (1 jour)
-0.30%
Changement (1 an)
22.90%
Pays
US
Échange DexCom, Inc. (DXCM)
Catégorie
Healthcare
Nombre d'actions en circulation pour DexCom, Inc. (DXCM)
Nombre d'actions en circulation au June 2026: 383.70M
Selon les derniers rapports financiers et le cours de l'action de DexCom, Inc., le nombre actuel d'actions en circulation est de 383.70M. À la fin de December 2024, l'entreprise avait 404.63M actions en circulation. Le nombre d'actions en circulation est généralement affecté par les divisions d'actions et les rachats d'actions.
Historique des actions en circulation de DexCom, Inc. (DXCM) de 2000 à 2026
Actions en circulation à la fin de chaque année
| Année | Actions en circulation | Changez |
|---|---|---|
| 2026 (TTM) | 383.70M | -1.67% |
| 2025 | 390.20M | -3.57% |
| 2024 | 404.63M | 4.83% |
| 2023 | 386.00M | -0.87% |
| 2022 | 389.40M | 0.65% |
| 2021 | 386.90M | 2.46% |
| 2020 | 377.60M | 3.62% |
| 2019 | 364.40M | 3.29% |
| 2018 | 352.80M | 2.20% |
| 2017 | 345.20M | 3.23% |
| 2016 | 334.40M | 4.76% |
| 2015 | 319.20M | 6.12% |
| 2014 | 300.80M | 5.77% |
| 2013 | 284.40M | 3.49% |
| 2012 | 274.80M | 4.73% |
| 2011 | 262.40M | 15.29% |
| 2010 | 227.60M | 28.31% |
| 2009 | 177.39M | 50.40% |
| 2008 | 117.95M | 4.15% |
| 2007 | 113.25M | 3.95% |
| 2006 | 108.94M | 43.77% |
| 2005 | 75.78M | 728.71% |
| 2004 | 9.14M | 5.35% |
| 2003 | 8.68M | 6.05% |
| 2002 | 8.18M | 7.89% |
| 2001 | 7.59M | 9.81% |
| 2000 | 6.91M | 0.00% |
Actions en circulation pour des entreprises similaires ou concurrentes
| Entreprise | Actions en circulation | Différence | Pays |
|---|---|---|---|
| 1.74B | 354.27% |
US
|
|
| 1.28B | 234.14% |
IE
|
|
| 383.50M | -0.05% |
US
|
|
| 1.48B | 285.09% |
US
|
|
| - | - |
DE
|
